Amoy Diagnostics Co., Ltd.
300685.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.92B
Close$
$22.42
18.7% upside
Current Fair Value
18.7% upsideUndervalued by 18.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.92 Billion |
|---|---|
| Enterprise Value | $7.07 Billion |
| Dividend Yield | $0.45 (2.22%) |
| Earnings per Share | $0.91 |
| Beta | 0.3 |
| Outstanding Shares | 381,550,869 |
Return
| Return on Equity | 17.86% |
|---|---|
| Return on Assets | 15.27% |
| Return on Invested Capital | 18.86% |
Valuation & Multiples
| P/E Ratio | 23.6 |
|---|---|
| PEG | -132.21 |
| Price to Sales | 6.29 |
| Price to Book Ratio | 4.72 |
| Enterprise Value to Revenue | 6 |
| Enterprise Value to EBIT | 17.92 |
| Enterprise Value to Net Income | 20 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.11 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 25, 2026
EPS Estimate
$0.21
Average shareholder expectationRevenue Estimate
$348.81 M
Average shareholder expectationNext Earnings Call
Expected Date
October 23, 2026
EPS Estimate
$0.21
Average shareholder expectationRevenue Estimate
$331.33 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Amoy Diagnostics Co., Ltd.
1,175 employees
CEO: Jiemin Luo Amoy Diagnostics Co., Ltd. is a Chinese company focused on oncology precision medicine. It engages in the research, development, production, and sale of molecular diagnostic products. The company provides a range of diagnostic reagents a...